Cargando…
Utilization of macrocyclic peptides to target protein-protein interactions in cancer
Protein-protein interactions (PPIs) play vital roles in normal cellular processes. Dysregulated PPIs are involved in the process of various diseases, including cancer. Thus, these PPIs may serve as potential therapeutic targets in cancer treatment. However, despite rapid advances in small-molecule d...
Autores principales: | Yang, Jiawen, Zhu, Qiaoliang, Wu, Yifan, Qu, Xiaojuan, Liu, Haixia, Jiang, Biao, Ge, Di, Song, Xiaoling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714258/ https://www.ncbi.nlm.nih.gov/pubmed/36465350 http://dx.doi.org/10.3389/fonc.2022.992171 |
Ejemplares similares
-
Two novel strategies to overcome the resistance to ALK tyrosine kinase inhibitor drugs: Macrocyclic inhibitors and proteolysis‐targeting chimeras
por: Song, Xiaoling, et al.
Publicado: (2021) -
Modulating Protein–Protein Interactions by Cyclic and Macrocyclic Peptides. Prominent Strategies and Examples
por: González-Muñiz, Rosario, et al.
Publicado: (2021) -
Transmembrane Peptides as Inhibitors of Protein-Protein Interactions: An Efficient Strategy to Target Cancer Cells?
por: Albrecht, Camille, et al.
Publicado: (2020) -
Cyclic and Macrocyclic Peptides as Chemical Tools To Recognise Protein Surfaces and Probe Protein–Protein Interactions
por: Cardote, Teresa A. F., et al.
Publicado: (2015) -
Rational design of a potent macrocyclic peptide inhibitor targeting the PD-1/PD-L1 protein–protein interaction
por: Miao, Qi, et al.
Publicado: (2021)